JPRN-UMIN000017547
Completed
未知
Acute phase platelet reactivity in patients with acute coronary syndrome - platelet reactivity in patients with acute coronary syndrome
ConditionsAcute Coronary syndrome
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute Coronary syndrome
- Sponsor
- Chiba University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients with contraindications to prasugrel 2\. Patients who have severe liver problem 3\. Patients who have severe kidney problem 4\. Weigh 45 kg or less 5\. low platelet counts (less than 10\*10^4\) 6\. Pregnant 7\. Patients who are taking anticoagulants 8\. Patients who are planned to administer thrombolytic agents 9\. Patients scheduled for PCI or coronary artery bypass graft during this study 10\. Patients who are taking ticlopidine or cilostazol 11\.Cardiogenic shock 12\.History of stroke or transient ischemic attack 13\. Patients judged as inappropriate for trial entry
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Platelet reactivity over time in patients undergoing vascular surgeryantiplatelet therapyatherosclerosis10003216NL-OMON46079niversitair Medisch Centrum Utrecht50
Completed
Not Applicable
Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic eventPatients with ACS or elective indications undergoing PCI with drug-eluting stent implantation.JPRN-UMIN000020332Toho University Ohashi Medical Center6,422
Completed
Not Applicable
Platelet Responsiveness and Outcome from Platelet Transfusion (PROmPT)ational Cancer Research Network, BloodCancerISRCTN56366401HS Blood and Transplant [NHSBT] (UK)130
Not yet recruiting
Not Applicable
Immature platelet fraction in patients infected with COVID-19Health Condition 1: U071- COVID 19 virus identifiedCTRI/2023/12/060412Rashmi Jain Gupta
Completed
Phase 4
The effects of aspirin and ticagrelor on infection-mediated platelet activation in healthy volunteers.Acute coronary syndromeCardiovascular - Coronary heart diseaseBlood - Normal development and function of platelets and erythrocytesACTRN12616001508460Kathryn Hally10